EDGEWISE THERAPEUTICS INC (EWTX:NASDAQ)
$33.56 0.86 (2.63%)
Analysed EDGEWISE THERAPEUTICS INC (EWTX:NASDAQ) News Sources
Do Edgewise Therapeutics' (EWTX) New Stock Grants Clarify or Complicate Its Pipeline Execution Story?
07-05-2026
yahoo.com
Edgewise Therapeutics' Update for EDG-7500 Could Boost Shares, RBC Says
08-05-2026
yahoo.com
Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 20, 2026
12-05-2026
yahoo.com
Why This Hedge Fund Added $29 Million to a Cancer Stock Already Up 700%
14-05-2026
fool.com
This Fund Has a $75 Million Bet on a Hair Loss Biotech Stock Up More Than 500% Post-IPO
14-05-2026
fool.com
What to Know About This Fund’s $50 Million Exit From Ascendis Pharma
14-05-2026
fool.com
Erasca Stock Is Up 715%. Here’s Why One Biotech Fund Still Bought $68 Million More
17-05-2026
fool.com
Why This Fund Just Made a $55 Million Bet on Dianthus Amid a 350% Stock Rally
17-05-2026
fool.com
Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter
17-05-2026
fool.com
Biotech Fund Sells $44.5 Million Erasca Stake After Massive 700% Rally
18-05-2026
fool.com
What is the current price of EDGEWISE THERAPEUTICS INC (EWTX:NASDAQ)?
The current price of EDGEWISE THERAPEUTICS INC (EWTX:NASDAQ) is $33.56.
EDGEWISE THERAPEUTICS INC (EWTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of EDGEWISE THERAPEUTICS INC (EWTX:NASDAQ) since the previous trading day is $0.86.
EDGEWISE THERAPEUTICS INC (EWTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of EDGEWISE THERAPEUTICS INC (EWTX:NASDAQ) since the previous trading day is 2.63%.
What is the most recent average sentiment score for EDGEWISE THERAPEUTICS INC (EWTX:NASDAQ)?
The most recent average sentiment score for EDGEWISE THERAPEUTICS INC (EWTX:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for EDGEWISE THERAPEUTICS INC (EWTX:NASDAQ)?
The most recent sentiment for EDGEWISE THERAPEUTICS INC (EWTX:NASDAQ) is .
SEC-8K** Filing Available For EDGEWISE THERAPEUTICS INC (EWTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.